Klingmann, I
28  results:
Search for persons X
?
1

Veränderungen durch die neue EU-Verordnung 536/2014 zu klin..:

Klingmann, Ingrid ; Paul, Margit ; Bereczky, Tamás...
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.  66 (2022)  1 - p. 68-74 , 2022
 
?
 
?
3

The Good Clinical Practice guideline and its interpretation..:

Vischer, N. ; Pfeiffer, C. ; Joller, A....
Tropical Medicine & International Health.  21 (2016)  8 - p. 1040-1048 , 2016
 
?
5

Eigenbewertung der Prüfeinrichtung:

, In: Good Clinical Practice II; Konzepte in der Humanpharmakologie,
Klingmann, I. - p. 117-124 , 1992
 
?
6

Regelung der Verantwortungen: Auftragnehmer:

, In: Good Clinical Practice I; Konzepte in der Humanpharmakologie,
Klingmann, I. - p. 123-128 , 1992
 
?
7

Effect of urapidil on steady-state serum digoxin concentrat..:

Solleder, P. ; Haerlin, R. ; Wurst, W...
European Journal of Clinical Pharmacology.  37 (1989)  2 - p. 193-194 , 1989
 
?
8

Interaction of bisoprolol with cimetidine and rifampicin:

Kirch, W. ; Rose, I. ; Klingmann, I...
European Journal of Clinical Pharmacology.  31 (1986)  1 - p. 59-62 , 1986
 
?
9

Toward a Regulatory Pathway for the Use of in Silico Trials..:

Pappalardo F ; Wilkinson J ; Busquet F...
info:eu-repo/semantics/altIdentifier/wos/WOS:000882005700005.  , 2022
 
?
10

Toward a Regulatory Pathway for the Use of in Silico Trials..:

Pappalardo F ; Wilkinson J ; Busquet F...
info:eu-repo/semantics/altIdentifier/pmid/35951559.  , 2022
 
?
11

Simulation Training to Improve Informed Consent and Pharmac..:

Burckhardt, BB ; Ciplea, AM ; Laven, A...
Burckhardt , BB , Ciplea , AM , Laven , A , Ablonczy , L , Klingmann , I , Läer , S , de Kleine , K , Dalinghaus , M , ?uki? , M , Breur , JMPJ , van der Meulen , M , Swoboda , V , Schwender , H & Lagler , FB 2020 , ' Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials ' , Frontiers in Pharmacology , vol. 11 , 603042 . https://doi.org/10.3389/fphar.2020.603042.  , 2020
 
?
12

Pharmacotherapeutic management of paediatric heart failure ..:

Díez, CC ; Khalil, F ; Schwender, H...
Díez , CC , Khalil , F , Schwender , H , Dalinghaus , M , Jovanovic , I , Makowski , N , Male , C , Bajcetic , M , van der Meulen , M , de Wildt , S , Ablonczy , L , Szatmári , A , Klingmann , I , Walsh , J & Läer , S 2019 , ' Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: A European survey ' , BMJ Paediatrics Open , vol. 3 , no. 1 , e000365 . https://doi.org/10.1136/bmjpo-2018-000365.  , 2019
 
?
14

Orodispersible minitablets of enalapril for use in children..:

Bajcetic, M ; de Wildt, Saskia ; Dalinghaus, M...
Bajcetic , M , de Wildt , S , Dalinghaus , M , Breitkreutz , J , Klingmann , I , Lagler , FB , Keatley-Clarke , A , Breur , J , Male , C , Jovanovic , I , Szatmari , A , Ablonczy , L , Burckhardt , BB , Cawello , W , de Kleine , K , Obarcanin , E , Spatenkova , L , Swoboda , V , van der Meulen , M , Wagner , P , Walsh , J & Laer , S 2019 , ' Orodispersible minitablets of enalapril for use in children with heart failure (LENA): Rationale and protocol for a multicentre pharmacokinetic bridging study and follow-up safety study ' , Contemporary Clinical Trials Communications , vol. 15 , Unsp 100393 . https://doi.org/10.1016/j.conctc.2019.100393.  , 2019
 
1-15